![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Prevalence of rilpivirine resistance-associated mutations in US samples received for routine resistance testing
|
|
|
Reported by Jules Levin
XIX International AIDS Conference, Washington DC, USA, July 22-27 2012
Gaston R Picchio,1 Laurence T Rimsky,2 Veerle Van Eygen,2 Mojgan Haddad,3 Laura A Napolitano,3 Johan Vingerhoets2
1Janssen Research & Development LLC, Titusville, NJ, USA; 2Janssen Infectious Diseases BVBA, Beerse, Belgium; 3Monogram Biosciences, South San Francisco, CA, USA
![IAC1.gif](../images/080612/080612-3/IAC1.gif)
![IAC2.gif](../images/080612/080612-3/IAC2.gif)
![IAC3.gif](../images/080612/080612-3/IAC3.gif)
![IAC4.gif](../images/080612/080612-3/IAC4.gif)
![IAC5.gif](../images/080612/080612-3/IAC5.gif)
![IAC6.gif](../images/080612/080612-3/IAC6.gif)
![IAC7.gif](../images/080612/080612-3/IAC7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|